Continuous growth of mean tumor diameter in a subset of grade II gliomas. - Wikidata - wikimedia - TriplyDB

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

http://www.wikidata.org/entity/Q48350477

about

ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies Malignant Transformation in Glioma Steered by an Angiogenic Switch: Defining a Role for Bone Marrow-Derived Cells Glioma surgery in eloquent areas: can we preserve cognition?Cognition and resective surgery for diffuse infiltrative glioma: an overview Vignettes from the field of mathematical biology: the application of mathematics to biology and medicine Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.Estimating Tumor Growth Rates In Vivo.Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.Microsurgical excisions of vestibular schwannomas: A tumor-size-based analysis of neurological outcomes and surgical complications.Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.Neuroimaging in glioma therapy.Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Advanced MRI in the management of adult gliomas.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis.An image-driven parameter estimation problem for a reaction-diffusion glioma growth model with mass effects Resting functional connectivity in patients with brain tumors in eloquent areas.Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Plasticity of language pathways in patients with low-grade glioma: A diffusion tensor imaging study.Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric A Molecular Predictor Reassesses Classification of Human Grade II/III Gliomas Current treatment of low grade gliomas Pathological neural attractor dynamics in slowly growing gliomas supports an optimal time frame for white matter plasticity PROX1 is a predictor of survival for gliomas WHO grade II Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424 Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma.Imaging of gliomas at 1.5 and 3 Tesla - A comparative study.Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.Functional rearrangement of the primary and secondary motor cortex in patients with primary tumors of the central nervous system located in the region of the central sulcus depending on the histopathological type and the size of tumor: Examination b Intraoperative cortico-subcortical stimulations in surgery of low-grade gliomas.Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey Increasing the Time Interval between PCV Chemotherapy Cycles as a Strategy to Improve Duration of Response in Low-Grade Gliomas: Results from a Model-Based Clinical Trial Simulation.'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle

P2860

Q26747496-8F6DEF56-8863-43C4-8348-021219D65F8E Q26765887-376A4B5C-0189-4D1F-93A9-B4C6172DE74F Q26777165-5CFBBCDA-1732-4A58-BB58-14F38F831A6E Q27026254-92097314-74D8-4130-AAB1-E154CF6E0919 Q28729108-951188E7-E3DB-4C4F-80A6-E470F69C87E9 Q30245146-0B51CA8D-7788-4E55-846F-87EB68ACB456 Q30373100-68254974-5150-47A7-BEE3-71E8D200D841 Q30463103-985C3DD1-BCDC-4D6E-A019-DE7ED8F75F96 Q30475737-E39B5DCF-957C-4FA3-8930-D7985DE84330 Q30967370-7A3F8700-8A25-41A0-AFB0-70D3AA98E098 Q30988178-A7790B5C-F811-4469-A13D-7424F8466293 Q30989913-1A5F4144-C520-4610-B92E-E0B2880C6346 Q31016200-2C3FFBCB-8006-459C-BE1E-4DD58F154524 Q31139548-F6EA6769-A7BE-4E99-8702-2F65C58DAAFC Q33399939-92D0F109-6667-4CE4-9C99-7B578FA47970 Q33447142-FC48820E-C178-4ECC-A018-3CCB27C6380D Q33703639-96096EF7-9E25-47EB-9B99-3C5D8FB10159 Q33729213-19BE4408-5A78-43B5-965E-793C51E1A977 Q33854863-45B8C82A-FFAB-4DEC-99A1-642F5092F706 Q33875985-252C2DB8-D1CA-41C8-9456-D69DAC253837 Q33894486-32D050A9-95BC-460D-9D87-2338B7EC903F Q34094919-E3A890AA-BB0C-4B1E-9326-18C92200DBA0 Q34117487-C2D6F6F4-0FCE-48AB-BEFA-E25B345CAEB7 Q34480589-DBB908BC-268C-473F-8D39-C8A82A9B342B Q34570841-A49D8D3E-2B6E-4289-9BF7-03B2C9D21A15 Q34785423-56D701EA-E025-4E7E-90B2-33FFD73536C8 Q34830708-CDFA5D55-B9E6-4F57-97C9-4414D3B760CE Q34903950-014EDBCE-81FA-4FE3-9B76-3D301459CD2B Q35034643-9D8DC7D1-5AD1-43B2-8929-6D1D6BB89E5B Q35085561-342364E1-3D99-49F7-A4BC-279CE81F14F2 Q35678312-D41C81DE-D33C-4CE7-A09D-94707A927BCB Q35788981-27AED573-AFA7-4947-873B-750C49E323FA Q35845266-EBD7EE9B-7A33-4B55-B80B-770B5ECACA47 Q36076831-063A3171-F234-4FCE-8BF8-3F2E4218715B Q36198598-74A6D0EA-135C-4DAE-BBFA-EE70448A0A3C Q36307794-9BF6855A-F5D5-40BF-AB76-64E666D2CB0A Q36381656-DE392AB4-16AB-4578-A8F8-B5F5E7477E96 Q36409030-0D81B6D2-753F-4EBE-B948-BB896A64E7BE Q36510818-0174F3A8-1A9D-46F0-9593-FF6A39F53DF8 Q36608763-5640364E-5FCB-4B7F-94A6-2A2B0FE74A06

P2860

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

http://www.wikidata.org/entity/Q48350477

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@en

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@nl

type

label

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@en

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@nl

prefLabel

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@en

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@nl

P1433

Q48350477-251A7DF9-6071-410B-ACBD-51A91FE0286C

P1476

Q48350477-FF01FD2B-AAC4-4371-A929-414448507A89

P2093

Q48350477-0520FCBB-1C2C-43C3-9ECB-B83A24A3E757

Q48350477-4F654660-6CCC-4D33-9410-DF997EB489AF

Q48350477-4FCADA6D-FA55-465A-BB4F-6A2E848BBE50

Q48350477-60A6153A-29FF-4B1B-B36A-692C2DE45B45

Q48350477-75E8B133-6EAB-45CB-B744-C237836A9CE8

Q48350477-815AF1C8-DEDE-4459-94E6-89387F6C5503

Q48350477-A7334CB5-AABF-4837-AFF8-791E3A17E19D

Q48350477-AF7EC153-EAB2-49D5-876B-1F3E3D396DB3

Q48350477-BD68BF98-171F-4F34-8AFE-20D7D2FEB6A0

Q48350477-C509F651-8F03-4386-91FC-7BAF7957839E

P304

Q48350477-C8FD8DB2-D1A3-4AFE-8157-430101951B93

P31

Q48350477-846F5F9F-8206-4077-B30D-9943A5718718

P356

Q48350477-6955162E-EE02-4F2B-B388-A139E136F576

P433

Q48350477-B8536A50-1454-4346-9F84-D4AEC4B4A59E

P478

Q48350477-1E59BBDA-BB38-44CA-BECE-F08948EF4159

P577

Q48350477-D745CA87-3A53-47A4-9E78-3BA835205975

P5875

Q48350477-4FB2ED40-8385-4B9C-862D-865B36DF5DDD

P698

Q48350477-7ED94525-AFE3-4DA8-AC46-AAD1E0D7B517

P356

P1433

Annals of Neurology

P1476

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

@en

P2093

Antoine F Carpentier

http://www.w3.org/2001/XMLSchema#string

Ellsworth C Alvord

http://www.w3.org/2001/XMLSchema#string

Emmanuel Mandonnet

http://www.w3.org/2001/XMLSchema#string

Hugues Duffau

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Delattre

http://www.w3.org/2001/XMLSchema#string

Kristin R Swanson

http://www.w3.org/2001/XMLSchema#string

Laurent Capelle

http://www.w3.org/2001/XMLSchema#string

Marie-Laure Tanguy

http://www.w3.org/2001/XMLSchema#string

Philippe Cornu

http://www.w3.org/2001/XMLSchema#string

Rémy Van Effenterre

http://www.w3.org/2001/XMLSchema#string

P304

524-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.10528

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10830380

http://www.w3.org/2001/XMLSchema#string

P698

12666121

http://www.w3.org/2001/XMLSchema#string